Michael Solomon
Director/Board Member at PROTARA THERAPEUTICS, INC.
Net worth: 80 825 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jesse Shefferman | M | 52 | 7 years | |
| Jacqueline Zummo | M | 43 | 7 years | |
| Kevin Weeks | M | - |
Ribometrix, Inc.
 Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | - |
| Luke Beshar | M | 65 | 6 years | |
| Barry Flannelly | M | 66 | 4 years | |
| Cynthia Smith | F | 55 | 3 years | |
| Elizabeth Blake Schwert | F | - |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | 6 years |
| Hannah Fry | F | 34 | 4 years | |
| Jane Huang | M | 51 | 3 years | |
| Justine O'Malley | M | - | 4 years | |
| Gregory Sargen | M | 58 | 5 years | |
| Patrick Crutcher | M | - |
ValenzaBio, Inc.
 ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | - |
| Barclay Phillips | M | 61 |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | 4 years |
| Roger Garceau | M | 70 | 5 years | |
| Katherine Warner | M | - |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | - |
| Richard Levy | M | 66 | 5 years | |
| Mary J. Grendell | F | - | - | |
| Zaven Kaprielian | M | - |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | 6 years |
| David Maizenberg | M | - |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | - |
| John Doux | M | - |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | - |
| James Silverman | M | - |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | - |
| Tatyana Touzova | F | - |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | - |
| Patrick Fabbio | M | 56 | 1 years | |
| Mike Dial | M | - |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | - |
| Michael Clayman | M | 72 |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | 5 years |
| Hakan Goker | M | 49 |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | - |
| William Marshall | M | 60 |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | - |
| Peter Greenleaf | M | 54 |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | - |
| Albert Prast | M | - |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | 7 years |
| Michael Ross | M | 75 |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | - |
| Christian Schubert | M | - |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Gould | M | 69 | 8 years | |
| John F. Dee | M | 66 |
Link Medicine Corp.
 Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Link Medicine Corp. develops disease modifying neurodegenerative therapies. The company was founded by Edward I. Rudman, Peter T. Lansbury, David Neafus and Adam J. Rosenberg in 2005 and is headquartered in Cambridge, MA. | 3 years |
| Steven Holtzman | M | 70 | 4 years | |
| Kevin Starr | M | 61 | 1 years | |
| Kazumi Shiosaki | M | 69 | 7 years | |
| Scott Braunstein | M | 60 | 2 years | |
| Timothy Noyes | M | 62 | 13 years | |
| Richard Pops | M | 62 | 12 years | |
| Beth Seidenberg | M | 67 | 11 years | |
| Leslie Shinobu | M | - | - | |
| Blaine Davis | M | 50 | 2 years | |
| Ashley Garry | M | - | 1 years | |
| Albert Edge | M | - | - | |
| M. Charles Liberman | M | - | - | |
| Gabriel Corfas | M | - | - | |
| Ulrich Müller | M | - | - | |
| Jeff Jonas | M | 71 | - | |
| Jackie Grant | M | - |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | - |
| Wouter Meuleman | M | - |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | - |
| Martín Sebastian Olivo | M | 48 | - | |
| Jathin Bandari | M | 37 | 4 years | |
| Robert Copeland | M | - | 9 years | |
| Jonathon Whitton | M | - | 7 years | |
| Ada Silos-Santiago | M | - | - | |
| Victoria Richon | M | 65 | 4 years | |
| Joseph Hernandez | M | 51 |
Ember Therapeutics, Inc. /Old/
 Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | 5 years |
| Yi Zhang | M | - | - | |
| Robert Poole | M | 67 |
Link Medicine Corp.
Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Link Medicine Corp. develops disease modifying neurodegenerative therapies. The company was founded by Edward I. Rudman, Peter T. Lansbury, David Neafus and Adam J. Rosenberg in 2005 and is headquartered in Cambridge, MA. | - |
| Jeff Saunders | M | - |
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | - |
| Julio Casoy | M | 72 | 1 years | |
| Craig D. Muir | M | - | - | |
| Zhang Yi | M | - | - | |
| David Milne | M | 61 |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | 12 years |
| H. Robert Horvitz | M | - | - | |
| Mike Schiavo | M | - |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | 2 years |
| Jens Eckstein | M | 60 | - | |
| Daniel Lynch | M | 65 |
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | 2 years |
| John D. Shagoury | M | 66 |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | - |
| Kristy Rosse | F | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 70 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Solomon
- Personal Network
